‘Covaxin estimated on Exactly Same Criteria as Others’: WHO on Bharat Biotech’s Claims of ‘So Much Scrutiny’

Covaxin estimated on exactly same criteria as Others says World Health Organization, refusing the claims of Bharat Biotech’s Chief Dr. Krishna Ella who questioned the “unrestricted” inspection.

0
93

Covaxin estimated on exactly same criteria as Others says World Health Organisation, refusing the claims of Bharat Biotech’s Chief Dr. Krishna Ella who questioned the “unrestricted” inspection.

“The emergency use recorded process as a neutral, scientifically attentive processs and non-political, with independent governing experts contributing to evaluations and advising WHO.”

WHO also added, “Covaxin was estimated according to the exact same criteria as other vaccines.”

Dr. Ella, chairman of the Hyderabad-based vaccine firm, on Wednesday said: “We are the only vaccine in the WHO that has gone through so much inspection which other vaccines have not gone through. But it’s good that in the end, we won the game.”

Added, “They wanted to be extra sure of what they were doing. So, they wanted to test much more deeply. Every small problem became a major one for them”

Covaxin is a whole virus-inactivated vaccine against SARS-CoV2, grew partnership with ICMR and NIV, Pune, Bharat Biotech said. With confirmation from the World Health Organisation (WHO), countries can now rushed their administrative approval processes to import and administer Covaxin, it added.

After going back and forth, WHO granted urgent recorded Covaxin use, adding tp the other vaccins validated by the global health body  for the reduction of Covid-19.

United Nation Children Fund (UNICEF), Pan-American Health Organization (PAHO) and GAVI COVAX facility will also be able to provide Covaxin for handing out to other countries, Bharat Biotech said.

LEAVE A REPLY

Please enter your comment!
Please enter your name here